期刊文献+

脑梗死患者血清ferritin、FA与VitB_(12)及血脂检测的临床意义 被引量:7

Clinical Significance of Determination of Changes of Serum Ferritin,FA,VitB_(12) Contents and Lipid Profile in Patients with Acute Cerebral Infarction
下载PDF
导出
摘要 目的:探讨血清ferritin、FA、VitB12及血脂在脑梗死患者中的变化及意义。方法:对78例脑梗死患者和64例体检者应用化学发光法检测血清ferritin、FA与VitB12浓度,生化分析仪检测血脂水平。结果:脑梗死患者血清ferritin浓度为(2.11±0.40)ng/ml,明显高于对照组(t=2.22,P<0.05);FA浓度为(5.51±4.36)ng/ml,明显低于对照组(t=4.03,P<0.001);而VitB12浓度脑梗死组为(492.71±338.92)pg/ml,低于对照组,但无显著性差异(t=1.13,P>0.05),脑梗死组TG、TC、LDL水平显著高于对照组,HDL显著低于对照组。结论:监测血清ferritin、FA及血脂水平,适当补充FA,可早期预防和及时治疗脑梗死。 Objective To study the significance of changes of serum ferritin(SF),folate(FA),VitB12 contents and lipid profile in patients with(acute)cerebral infarction.Methods Serum ferritin,FA,VitB12(with CLIA)contents and lipid profile(with biochemistry)were determined in 78 patients with cerebral infarction on 2nd day of the disease and 64 controls.Results Serum ferritin levels(2.11±0.40ng/ml)in the patients were significantly higher than those in controls(P0.05),while the serum FA levels(5.51±4.36ng/ml)were significantly lower(P0.001).The serum VitB12 contents(492.71±338.92pg/ml)were only insignificantly lower than those in controls(P0.05).The TG,TC and LDL-C levels in the patients were significantly higher but the HDL-C levels were significantly lower than those in the controls.Conclusion Monitoring changes of those variables with adequate supplement of FA is clinically useful in the treatment of patients with acute cerebral infarction.
出处 《放射免疫学杂志》 CAS 2010年第3期349-351,共3页 Journal of Radioimmanology
关键词 血清铁蛋白 叶酸 维生素B12 血脂 脑梗死 serum ferritin(SF) folate(FA) vitaminB12 serum lipid cerebral infarction
  • 相关文献

参考文献6

二级参考文献17

  • 1中华医学会全国第四次脑血管病学术会议.脑卒中患者临床神经功能缺损评分标准[J].中华神经科杂志,1996,29:381-381.
  • 2Daly LE,Kirkw PN,Mollou A,et al.Folate levels and neuraltube defects implications for prevention[J].JAMA,1995,274(21):1698 -1702
  • 3Stampfer MJ,Mahinow MR, Willet WC,et al.Aprospective study of plasma homocysteine and risk of myocardial infarction in US physicians[J].JAMA, 1992,268(7):877-881
  • 4Verhoef P,Stampfer MJ. Prospective studies of homocysteine and cardiovascular disease [J].NutrRev,1995,53(10):283-288
  • 5Rimm EB, Willett WC,Hu FB, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women [J].JAMA,1998,279(5):359-364
  • 6Ross R.Atherosclerosis-an inflammatory disease.N Engl J Med.1999,340(2):115.
  • 7Paul M Ridker,Nancy J,Douglas E,et al.Establishd and emergine plasma biomarkers in the prediction of first atherothrombotic events.Circulation.2004,109[suppl Ⅳ]:Ⅳ-6.
  • 8Ledue TB,Rifai N.Preanalytic and analytic sources of variations in C-reactive protein measurement:implications for cardiovascular disease risk assessment.Clin Chem.2003,49:1258.
  • 9Szmitko PE,Wang CH,Weisel RD,et al.New markers of inflammation and endothelial cell activation:Part Ⅰ.Circulation.2003,108:1917.
  • 10Danenberg HD,Szalai AJ,Swaminathan RV,et al.Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.Circulation.2003,108:512.

共引文献33027

同被引文献68

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部